INSIGHTS ON DRUG DEVELOPMENT

• A CDMO Is The Nexus Between Green Chemistry And Commercialization

  Modern R&D transforms sustainability from an optional add-on into a strategic optimization tool, enhancing cost-efficiency, speed to market, and process intensification for drug developers.

• Cell Retention Technology And Specialized Cell Culture Media

  Explore how perfusion technology is transforming upstream bioprocessing by boosting productivity, reducing costs, and enabling process intensification while overcoming cell retention challenges.

• Organ-Chips For Drug Development

  Delve into how Organ-on-Chip technology significantly enhances drug development processes and improves the accuracy of clinical translation, leading to more effective and reliable therapeutic outcomes.

• ADC Tech Talks Contract Manufacturing

  Experts share strategies to accelerate ADC development, including optimizing supply chains, seamless scale-up to GMP manufacturing, and leveraging process analytical technology.

• Measuring Thermodynamic Parameters In The Drug Development Process

  4/29/2025

  Join Dr. Ladbury to explore how thermodynamic data can enhance our understanding of protein-ligand interactions and how it is crucial for optimizing drug efficacy and safety in pharmaceutical development.

• Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS

  7/29/2025

  Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.

• A Case Study Of The GLP-1 Receptor Agonist, Semaglutide, In Plasma

  7/31/2025

  Light scattering reveals critical insights into the structural integrity, aggregation, and stability of GLP-1 analogs, which are essential for optimizing drug formulations and improving treatments.

• Delivering Critical Therapies With Speed And Safety

  6/26/2026

  Faster approvals depend on treating regulation as part of development, not the finish line. See how early quality planning and strong agency communication can move therapies toward patients sooner.

• Selecting A CDMO For Custom Activated PEGs

  1/27/2026

  Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.